Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.

Nickerson M, Marrie RA.

BMC Neurol. 2013 Sep 10;13:119. doi: 10.1186/1471-2377-13-119.

PMID:
24016260
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.

Hadjimichael O, Vollmer T, Oleen-Burkey M; North American Research Committee on Multiple Sclerosis.

Health Qual Life Outcomes. 2008 Nov 14;6:100. doi: 10.1186/1477-7525-6-100.

PMID:
19014588
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.

Burton JM, O'Connor PW, Hohol M, Beyene J.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD006921. doi: 10.1002/14651858.CD006921.pub3. Review.

PMID:
23235634
[PubMed - indexed for MEDLINE]
4.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
[PubMed - indexed for MEDLINE]
5.

Oral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosis.

Perumal JS, Caon C, Hreha S, Zabad R, Tselis A, Lisak R, Khan O.

Eur J Neurol. 2008 Jul;15(7):677-80. doi: 10.1111/j.1468-1331.2008.02146.x. Epub 2008 May 6.

PMID:
18459972
[PubMed - indexed for MEDLINE]
6.

Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.

Burton JM, O'Connor PW, Hohol M, Beyene J.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006921. doi: 10.1002/14651858.CD006921.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD006921.

PMID:
19588409
[PubMed - indexed for MEDLINE]
7.

Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.

Tremlett HL, Luscombe DK, Wiles CM.

J Neurol Neurosurg Psychiatry. 1998 Sep;65(3):362-5.

PMID:
9728950
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.

Filippini G, Del Giovane C, Vacchi L, D'Amico R, Di Pietrantonj C, Beecher D, Salanti G.

Cochrane Database Syst Rev. 2013 Jun 6;6:CD008933. doi: 10.1002/14651858.CD008933.pub2. Review.

PMID:
23744561
[PubMed - indexed for MEDLINE]
9.

Disparities in the management of multiple sclerosis-related bladder symptoms.

Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D.

Neurology. 2007 Jun 5;68(23):1971-8.

PMID:
17548546
[PubMed - indexed for MEDLINE]
10.

Responsiveness of walking-based outcome measures after multiple sclerosis relapses following steroid pulses.

Filipović Grčić P, Matijaca M, Lušić I, Čapkun V.

Med Sci Monit. 2011 Dec;17(12):CR704-10.

PMID:
22129902
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Cognitive reserve and symptom experience in multiple sclerosis: a buffer to disability progression over time?

Schwartz CE, Quaranto BR, Healy BC, Benedict RH, Vollmer TL.

Arch Phys Med Rehabil. 2013 Oct;94(10):1971-81. doi: 10.1016/j.apmr.2013.05.009. Epub 2013 May 28.

PMID:
23727344
[PubMed - indexed for MEDLINE]
12.

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.

Neurology. 2001 Oct 9;57(7):1239-47.

PMID:
11591843
[PubMed - indexed for MEDLINE]
13.

Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.

Nos C, Sastre-Garriga J, Borràs C, Río J, Tintoré M, Montalban X.

Mult Scler. 2004 Aug;10(4):413-6.

PMID:
15327039
[PubMed - indexed for MEDLINE]
14.

A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis.

Fierro B, Salemi G, Brighina F, Buffa D, Conte S, La Bua V, Piazza A, Savettieri G.

Acta Neurol Scand. 2002 Mar;105(3):152-7.

PMID:
11886356
[PubMed - indexed for MEDLINE]
15.

Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial.

Köpke S, Kasper J, Mühlhauser I, Nübling M, Heesen C.

Mult Scler. 2009 Jan;15(1):96-104. doi: 10.1177/1352458508095921. Epub 2008 Oct 9.

PMID:
18845657
[PubMed - indexed for MEDLINE]
16.

Persistent pain and uncomfortable sensations in persons with multiple sclerosis.

Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T.

Pain. 2007 Jan;127(1-2):35-41. Epub 2006 Sep 1.

PMID:
16949751
[PubMed - indexed for MEDLINE]
17.

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.

Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, Ebers GC.

Brain. 2010 Jul;133(Pt 7):1914-29. doi: 10.1093/brain/awq118. Epub 2010 Jun 9.

PMID:
20534650
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Mitoxantrone for multiple sclerosis.

Martinelli Boneschi F, Vacchi L, Rovaris M, Capra R, Comi G.

Cochrane Database Syst Rev. 2013 May 31;5:CD002127. doi: 10.1002/14651858.CD002127.pub3. Review.

PMID:
23728638
[PubMed - indexed for MEDLINE]
19.

Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.

Filippini G, Brusaferri F, Sibley WA, Citterio A, Ciucci G, Midgard R, Candelise L.

Cochrane Database Syst Rev. 2000;(4):CD001331. Review.

PMID:
11034713
[PubMed - indexed for MEDLINE]
20.

Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry.

Mahajan ST, Patel PB, Marrie RA.

J Urol. 2010 Apr;183(4):1432-7. doi: 10.1016/j.juro.2009.12.029. Epub 2010 Feb 20.

PMID:
20171697
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk